These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 3190902)

  • 1. Decreased membrane fluidity in polymorphonuclear cells in psoriasis.
    Offidani AM; Simonetti O; Cerioni S; Ferretti G; Marchiseppe I; Postiglione MR; Valentino M
    Boll Soc Ital Biol Sper; 1988 Jun; 64(6):495-500. PubMed ID: 3190902
    [No Abstract]   [Full Text] [Related]  

  • 2. Membrane fluidity changes in polymorphonuclear leukocytes and erythrocytes in psoriasis.
    Offidani AM; Simonetti O; Ferretti G; Curatola G; Bossi G
    Acta Derm Venereol Suppl (Stockh); 1989; 146():39-41. PubMed ID: 2609879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in membrane properties of erythrocytes and polymorphonuclear cells in psoriasis.
    Ferretti G; Offidani AM; Simonetti O; Valentino M; Curatola G; Bossi G
    Biochem Med Metab Biol; 1989 Apr; 41(2):132-8. PubMed ID: 2719858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of polymorphonuclear leukocyte membrane fluidity in patients with viral hepatitis.
    Fan XG; Zhang Z
    Chin Med J (Engl); 1993 Jan; 106(1):73-5. PubMed ID: 8504691
    [No Abstract]   [Full Text] [Related]  

  • 5. Polymorphonuclear leukocyte function in psoriasis vulgaris.
    Csató M; Dobozy A; Hunyadi J; Simon N
    Dermatol Monatsschr; 1983 Apr; 169(4):238-42. PubMed ID: 6345228
    [No Abstract]   [Full Text] [Related]  

  • 6. [Zinc levels in the leukocytes and serum of patients with psoriasis during the active phase and during remission associated with the chemotactic activity of polymorphonuclear leukocytes].
    Wasik F; Baran E; Walów B; Sierawska M; Waniewska I; Kaniowska E; Podwiński P; Andrzejak R
    Przegl Dermatol; 1985; 72(3):237-42. PubMed ID: 4081068
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chemotactic activity of polymorphonuclear granulocytes in patients with psoriasis].
    Wasik F; Miklaszewska M; Dabrowska-Widera J
    Przegl Dermatol; 1983; 70(5-6):493-6. PubMed ID: 6669719
    [No Abstract]   [Full Text] [Related]  

  • 8. Persistence of the altered polymorphonuclear leukocyte rheological and metabolic variables after 12 months in juvenile myocardial infarction.
    Lo Presti R; Tozzi Ciancarelli MG; Hoffmann E; Incalcaterra E; Canino B; Montana M; D'Amico T; Catania A; Caimi G
    Clin Hemorheol Microcirc; 2006; 35(1-2):227-30. PubMed ID: 16899933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphonuclear leukocyte membrane fluidity and cytosolic Ca2+ content in different clinical conditions.
    Caimi G; Canino B; Montana M; Ventimiglia G; Catania A; Lo Presti R
    Clin Hemorheol Microcirc; 1997; 17(3):217-23. PubMed ID: 9356786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD147 is highly expressed on peripheral blood neutrophils from patients with psoriasis and induces neutrophil chemotaxis.
    Lu H; Kuang YH; Su J; Chang J; Wu LS; Kanekura T; Li D; Chen ML; Chen X
    J Dermatol; 2010 Dec; 37(12):1053-6. PubMed ID: 21083710
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of Etretinate on the neutrophil chemotaxis in pustular psoriasis.
    Pigatto PD; Brugo AM; Finzi AF
    Boll Ist Sieroter Milan; 1982 May; 61(2):112-5. PubMed ID: 7126334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of PUVA therapy on the chemotaxis of neutrophilic granulocytes in various types of psoriasis].
    Kaben U; Westphal HJ
    Dermatol Monatsschr; 1986; 172(8):493-7. PubMed ID: 3770254
    [No Abstract]   [Full Text] [Related]  

  • 13. Erythrocyte, platelet and polymorphonuclear leukocyte membrane dynamic properties in essential hypertension.
    Caimi G
    Clin Hemorheol Microcirc; 1997; 17(3):199-208. PubMed ID: 9356784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential hypertension: polymorphonuclear leukocyte membrane fluidity at baseline and after chemotactic activation.
    Caimi G; Lo Presti R; Canino B; Montana M; Cerasola G
    Am J Hypertens; 1999 Sep; 12(9 Pt 1):947-8. PubMed ID: 10509556
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclosporine A inhibits polymorphonuclear leukocyte chemotaxis in vivo.
    Pigatto PD; Mozzanica N; Polenghi MM; Altomare GF; Finzi AF
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):91-4. PubMed ID: 3381307
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chemokinetic behavior of polymorphonuclear granulocytes in psoriasis].
    Westphal HJ; Kaben U
    Dermatol Monatsschr; 1987; 173(3):163-6. PubMed ID: 3595931
    [No Abstract]   [Full Text] [Related]  

  • 17. The functions of polymorphonuclear leukocytes emigrating into the skin in psoriasis.
    Csató M; Dobozy A; Simon N
    Dermatol Monatsschr; 1985; 171(6):372-5. PubMed ID: 3894081
    [No Abstract]   [Full Text] [Related]  

  • 18. The "metabolic burst" in polymorphonuclear leukocytes: in vitro reduction by scale extract of psoriasis.
    Muti S; Offidani AM; Fortunati R; Silveri F; Piergiacomi G
    Boll Soc Ital Biol Sper; 1988 Feb; 64(2):123-30. PubMed ID: 3166789
    [No Abstract]   [Full Text] [Related]  

  • 19. Behavior of the polymorphonuclear leukocyte membrane fluidity and cystolic Ca2+ content in vascular atherosclerotic disease with and without non-insulin-dependent diabetes mellitus.
    Caimi G; Canino B; Montana M; Ferrara F; Ventimiglia G; Meli F; Romano A; Catania A; Lo Presti R
    Clin Hemorheol Microcirc; 1997; 17(6):429-36. PubMed ID: 9502527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphonuclear leukocyte membrane fluidity and cytosolic Ca(2+) content in young adults with acute myocardial infarction. Evaluation at the initial stage and after 12 months.
    Caimi G; Hoffmann E; Canino B; Montana M; Dispensa F; Incalcaterra E; Casciolo MF; Catania A; Lo Presti R
    Clin Hemorheol Microcirc; 2004; 31(1):41-7. PubMed ID: 15272152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.